Q3 2023 Holdings
Filed 2023-11-14 | 63 holdings | $2.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $151.5M | 6,000,000 | 5.8% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $147.3M | 1,138,045 | 5.7% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $135.4M | 2,600,000 | 5.2% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $128.6M | 2,834,069 | 5.0% |
| Guardant Health Inc(GH) | COM | 40131M109 | $120.0M | 4,050,000 | 4.6% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $107.4M | 2,797,955 | 4.1% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $106.4M | 3,800,000 | 4.1% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $99.8M | 6,756,956 | 3.9% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $96.6M | 1,915,000 | 3.7% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $95.4M | 5,500,000 | 3.7% |
| Springworks Therapeutics Inc | COM | 85205L107 | $82.0M | 3,546,435 | 3.2% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $79.7M | 1,140,745 | 3.1% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $70.1M | 3,490,506 | 2.7% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $65.9M | 7,370,000 | 2.5% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $63.2M | 2,000,000 | 2.4% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $55.4M | 7,101,935 | 2.1% |
| Geron Corp(GERN) | COM | 374163103 | $54.5M | 25,700,000 | 2.1% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $52.0M | 3,187,415 | 2.0% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $51.4M | 2,414,373 | 2.0% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $50.1M | 6,000,000 | 1.9% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $45.5M | 2,963,267 | 1.8% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $40.4M | 2,500,000 | 1.6% |
| Hillevax Inc | COM | 43157M102 | $39.0M | 2,900,000 | 1.5% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $37.1M | 3,067,731 | 1.4% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $35.8M | 31,697,539 | 1.4% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $35.4M | 2,778,107 | 1.4% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $35.0M | 15,000,000 | 1.3% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $33.8M | 300,000 | 1.3% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $30.2M | 6,000,000 | 1.2% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $24.9M | 1,500,000 | 1.0% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $24.4M | 1,015,641 | 0.9% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $24.2M | 1,345,813 | 0.9% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $23.8M | 1,930,894 | 0.9% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $23.6M | 2,997,830 | 0.9% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $23.2M | 400,000 | 0.9% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $23.1M | 1,259,335 | 0.9% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $21.7M | 200,000 | 0.8% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $21.5M | 2,403,672 | 0.8% |
| Moderna Inc(MRNA) | COM | 60770K107 | $20.7M | 200,000 | 0.8% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $19.2M | 1,951,580 | 0.7% |
| Point Biopharma Global Inc | COM | 730541109 | $18.6M | 2,781,565 | 0.7% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $16.7M | 2,523,000 | 0.6% |
| Orchard Therapeutics PLC | SPON ADS NEW | 68570P200 | $15.8M | 2,041,670 | 0.6% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $15.8M | 2,750,000 | 0.6% |
| Prothena Corp PLC(PRTA)Put | SHS | G72800108 | $12.1M | 250,000 | 0.5% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $11.0M | 18,400,000 | 0.4% |
| Morphic Hldg Inc | COM | 61775R105 | $10.8M | 470,647 | 0.4% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $10.5M | 422,247 | 0.4% |
| Acumen Pharmaceuticals Inc(ABOS) | COM | 00509G209 | $10.4M | 2,513,044 | 0.4% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $10.3M | 7,720,688 | 0.4% |